BioNTech SE's market cap is currently ―. The company's EPS TTM is $4.157; its P/E ratio is 21.29; BioNTech SE is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	-	€ 3.20B	€ 6.37B
Gross Profit	-	-	-	€ 2.03B	€ 4.79B
EBIT	-	-	-	€ 2.33B	€ 5.02B
EBITDA	-	-	-	€ 2.36B	€ 5.05B
Net Income Common Stockholders	-	-	-	€ 1.67B	€ 3.70B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 16.55B	€ 13.88B	€ 0.00	€ 9.33B	€ 6.17B
Total Assets	€ 23.01B	€ 23.28B	-	€ 21.16B	€ 20.30B
Total Debt	€ 219.10M	€ 212.20M	€ 0.00	€ 238.90M	€ 186.00M
Net Debt	€ -16.33B	€ -13.66B	€ 0.00	€ -9.10B	€ -5.98B
Total Liabilities	€ 2.76B	€ 3.22B	-	€ 4.32B	€ 4.39B
Stockholders Equity	€ 20.25B	€ 20.06B	€ 0.00	€ 16.83B	€ 15.91B
Cash Flow	-
Free Cash Flow	-	-	-	€ 3.84B	€ 3.99B
Operating Cash Flow	-	-	-	€ 3.92B	€ 4.05B
Investing Cash Flow	-	-	-	€ -78.40M	€ 287.40M
Financing Cash Flow	-	-	-	€ -781.50M	€ 80.30M

Currency in EUR

BioNTech SE Earnings and Revenue History

Income Statement >

BioNTech SE Debt to Assets

Balance Sheet >

BioNTech SE Cash Flow

Cash Flow >

BioNTech SE Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing